Comments to the document GEPI-SEIMC screening recommendations for patients with suspected strongyloidosis
| Errataetall: |
CommentOn: Enferm Infecc Microbiol Clin. 2022 Aug-Sep;40(7):411-412. - PMID 35469335 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
|---|---|
| Enthalten in: |
Enfermedades infecciosas y microbiologia clinica (English ed.) - 40(2022), 7 vom: 24. Aug., Seite 411-412 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wikman-Jorgensen, Philip [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 02.08.2022 Date Revised 19.10.2022 published: Print-Electronic CommentOn: Enferm Infecc Microbiol Clin. 2022 Aug-Sep;40(7):411-412. - PMID 35469335 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.eimce.2022.05.004 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM341463744 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM341463744 | ||
| 003 | DE-627 | ||
| 005 | 20231226011834.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.eimce.2022.05.004 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1138.xml |
| 035 | |a (DE-627)NLM341463744 | ||
| 035 | |a (NLM)35624067 | ||
| 035 | |a (PII)S2529-993X(22)00106-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wikman-Jorgensen, Philip |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Comments to the document GEPI-SEIMC screening recommendations for patients with suspected strongyloidosis |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.08.2022 | ||
| 500 | |a Date Revised 19.10.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Enferm Infecc Microbiol Clin. 2022 Aug-Sep;40(7):411-412. - PMID 35469335 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 700 | 1 | |a Requena-Méndez, Ana |e verfasserin |4 aut | |
| 700 | 1 | |a Navarro, Miriam |e verfasserin |4 aut | |
| 700 | 1 | |a Llenas-García, Jara |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Enfermedades infecciosas y microbiologia clinica (English ed.) |d 2012 |g 40(2022), 7 vom: 24. Aug., Seite 411-412 |w (DE-627)NLM220666776 |x 2529-993X |7 nnns |
| 773 | 1 | 8 | |g volume:40 |g year:2022 |g number:7 |g day:24 |g month:08 |g pages:411-412 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.eimce.2022.05.004 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 40 |j 2022 |e 7 |b 24 |c 08 |h 411-412 | ||